Advertisement

The Blood-Brain Barrier in Cerebral Amyloidogenesis in Alzheimer’s Disease and Scrapie

  • P. Eikelenboom
  • H. Fraser
  • J. M. Rozemuller
  • F. C. Stam
Conference paper
Part of the Research and Perspectives in Alzheimer’s Disease book series (ALZHEIMER)

Summary

There is a diversity of opinions concerning the defect in the blood-brain barrier permeability in Alzheimer’s disease and in scrapie. In this paper we review the evidence for blood-brain barrier dysfunction and for serum factors and blood-borne cells in cerebral amyloidogenesis in Alzheimer’s dementia and in scrapie. The hypothetical role of immunologically mediated injury to the central nervous system in both disorders is discussed. The basis of the different conclusions is identified, and much of the evidence supporting a systematic or haematogeneous origin for cerebral amyloidosis is shown to arise from the unreliability or variation in histochemical techniques, from the inappropriate use of “markers” and from false interpretations based on localisation of proteins and antigens. It is concluded that the primary pathogenesis of plaques occurs within the neuroparenchyma and that the evidence for systemic involvement remains inconclusive.

Keywords

Amyloid Plaque Senile Plaque Amyloid Fibril Complement Factor Amyloid Plaque Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alafuzoff I, Adolfsson R, Bucht G, Winbald B (1983) Albumin and immunoglobulin in plasma and cerebrospinal fluid and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer’s disease and multi-infarct dementia. J Neurol Sci 60: 465–472PubMedCrossRefGoogle Scholar
  2. Alafuzoff I, Adolfsson R, Grundke-Iqbal I, Winblad B (1985) Perivascular deposits of serum proteins in cerebral cortex in vascular dementia. Acta Neuropathol (Berl) 66: 292–298CrossRefGoogle Scholar
  3. Alafuzoff I, Adolfsson R, Grundke-Iqbal I, Winblad B (1987) Blood-brain barrier in Alzheimer dementia and in non-demented elderly. Acta Neuropathol (Berl) 73: 160–166CrossRefGoogle Scholar
  4. Bruce ME, Fraser H (1975) Amyloid plaques in the brains of mice infected with scrapie: morphological variation and staining properties. Neuropathol Appl Neurobiol 1: 189–202CrossRefGoogle Scholar
  5. Budka H, Majdic O. (1985) Shared antigenic determinants between human hemopoietic cells and nervous tissues and tumors. Acta Neuropathol (Berl) 67: 58–66CrossRefGoogle Scholar
  6. Chapel HM, Esiri MM, Wilcock GK (1984) Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer’s disease. J Clin Pathol 37: 697–699PubMedCrossRefGoogle Scholar
  7. Cohen D, Eisorfer C (1980) Serum immunoglobulins and cognitive status in the elderly: I. A population study. Br J Psychiatry 136: 33–39PubMedCrossRefGoogle Scholar
  8. Collis SC, Kimberlin RH (1983) Further studies on changes in immunoglobulin G in the sera and CSF of Herdwick sheep with natural and experimental scrapie. J Comp Pathol 93: 331–338PubMedCrossRefGoogle Scholar
  9. Collis SC, Kimberlin RH, Millson GC (1979) Immunoglobulin G concentration in the sera of Herdwick sheep with natural scrapie. J Comp Pathol 89: 389–396PubMedCrossRefGoogle Scholar
  10. DeArmond, SJ, McKinley MP, Barry RA, Branfeld MB, McColloch JR, Prusiner SB (1985) Identification of prion amyloid filament in scrapie-infected brain. Cell 41: 221–235PubMedCrossRefGoogle Scholar
  11. Eikelenboom, P, Stam FC (1982) Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol (Berl) 57: 239–242CrossRefGoogle Scholar
  12. Eikelenboom P, Stam FC (1984) An immunohistocnemical study on cerebral vascular and senile plaque amyloid in Alzheimer’s. Virchows Arch [B] 47: 17–25CrossRefGoogle Scholar
  13. Eikelenboom P, Scott JR, McBride PA, Rozemuller JM, Bruce ME, Fraser H (1987) No evidence for involvement of plasmaproteins or blood-borne cells in amyloid plaque formation in scrapie-affected mice. Virchows Arch [B] 53: 251–256CrossRefGoogle Scholar
  14. Elovaara I, Icen A, Palo J, Erkinjuntti T (1985) CSF in Alzheimer’s disease. Studies on blood-brain barrier function and intrathecal protein synthesis. J Neurol Sci 70: 73–80PubMedCrossRefGoogle Scholar
  15. Esiri MM, Taylor CR, Mason DY (1976) Application of an immunoperoxidase method to a study on the central nervous system: preliminary findings in a study on human formalin-fixed material. Neuropathol Appl Neurobiol 2: 233–246CrossRefGoogle Scholar
  16. Fierz W, Endler B, Reske K, Wekerle H, Fontana A (1985) Induction of Ia antigen expression on astrocytes by T cells. Gamma immune interferon and its effect on antigen presentation. J Immunol 134: 3785–3793PubMedGoogle Scholar
  17. Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E (1982) Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol 129: 2413–2419PubMedGoogle Scholar
  18. Friede RL (1965) Enzyme histochemical studies of senile plaques. J Neuropathol Exp Neurol 24: 477–491CrossRefGoogle Scholar
  19. Friedland RP, Yano Y, Budinger TF, Ganz E, Huesman RH, Derenzo SE, Knittel B (1983) Quantitative evaluation of blood brain barrier integrity in Alzheimer-type dementia: positron emission tomographic studies with rubidium-82. Eur Neurol (Suppl) 22: 19–20Google Scholar
  20. Glenner GG (1979) Congophilic microangiopathy in the pathogenesis of Alzheimer’s syndrome (presenile dementia). Med Hypotheses 5: 1231–1236PubMedCrossRefGoogle Scholar
  21. Glenner GG (1980) Amyloid deposits and amyloidosis. N Engl J Med 302: 1283–1291, 1333–1343PubMedCrossRefGoogle Scholar
  22. Glenner GG (1986) On primal causes in Alzheimer’s disease. Neurobiol Aging 7: 506–508CrossRefGoogle Scholar
  23. Glenner GG, Wong CW Y(1984) Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122: 1131–1135Google Scholar
  24. Hardy JA, Mann DMA, Wester P, Winblad B (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s disease. Neurobiol Aging 7: 489–502PubMedCrossRefGoogle Scholar
  25. Henschke PJ, Bell DA, Cape RTD (1979) Immunologic indices in Alzheimer dementia. J Clin Exp Gerontol 1: 23–37Google Scholar
  26. Hikita K, Tateishi J, Nagara H (1985) Morphogenesis of amyloid plaques in mice with Creutzfeldt-Jakob disease. Acta Neuropathol (Berl) 68: 138–144CrossRefGoogle Scholar
  27. Ishii T, Haga S, Schimuzu F (1975) Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique. Acta Neuropathol (Berl) 32: 157–162CrossRefGoogle Scholar
  28. Ishii T, Haga S (1976) Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques. Acta Neuropathol (Berl) 36: 243–249CrossRefGoogle Scholar
  29. Ishii T, Haga S (1984) Immune-electron microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol (Berl) 63: 296–300CrossRefGoogle Scholar
  30. Jonker C, Eikelenboom P, Tavenier P (1982) Immunological indices in the cerebrospinal fluid of patients with presenile dementia of the Alzheimer type. Br J Psychiatry 140: 44–49PubMedCrossRefGoogle Scholar
  31. Katenkamp D, Stiller D, Thoss K (1970) Untersuchungen zum immunohistochemischen Verhalten der senilen Plaques des menschlichen Gehirnes. Virchows Arch [A] 351: 333–339Google Scholar
  32. Kay AD, May C, Papadopoulos NM, Costello R, Atack JR, Luxenberg JS, Cutler NR (1987) CSF and serum concentrations of albumin and IgG in Alzheimer’s disease. Neurobiol Aging 8: 21–25PubMedCrossRefGoogle Scholar
  33. Krigman MR, Feldman RG, Bench K (1965) Alzheimer’s presenile dementia — a histochemic and electronmicroscopic study. Lab Invest 14: 381–396PubMedGoogle Scholar
  34. Leonardi A, Gaandolfo C, Caponnetto C, Arata L, Vecchia R (1998) The integrity of the blood-brain barrier in Alzheimer’s type and multi-infarct dementia evaluated by the study of albumin and IgG in the serum and cerebrospinal fluid. J Neurol Sci 67: 253–261Google Scholar
  35. Mallat M, Levi-Strauss M (1987) Astrocytic production of complement components: C3c and factor B (Abstract). J Neuroimmunol 16: 114–115Google Scholar
  36. Mann DMA (1985) The neuropathology of Alzheimer’s disease: a review with pathogenetic, aetiological and therapeutic considerations. Mech Ageing Dev 31: 213–255PubMedCrossRefGoogle Scholar
  37. Mann DMA, Davies JS, Hawkes J, Yates PO (1982) Immunohistocnemical staining of senile plaques. Neuropathol Appl Neurobiol 8: 55–61PubMedCrossRefGoogle Scholar
  38. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245–4249PubMedCrossRefGoogle Scholar
  39. Merrill JE (1987) Macroglia: neural cells responsive to lymphokines and growth factors. Immunol Today 8: 146–150CrossRefGoogle Scholar
  40. Merz GS, Schwenk V, Schuller-Levis S, Gruca S, Wisniewski HM (1987) Isolation and characterization of macrophages from scrapie-infected mouse brain. Acta Neuropathol (Berl) 72: 240–247CrossRefGoogle Scholar
  41. Moretz RC, Wisniewski HM, Lossinski AS (1983) Pathogenesis of neuritic and amyloid plaques in scrapie — ultrastructural study of early changes in the cortical neuropil. In: Samuel D et al. (eds) Aging of the brain. Raven, New York, pp 61–79Google Scholar
  42. Oehmichen M (1982) Are resting and/or reactive microglia macrophages? Immunobiology 161: 246–254PubMedCrossRefGoogle Scholar
  43. Pouplard A, Emile J (1985) New immunological findings in senile dementia. Interdisc Top Gerontol 19: 62–71Google Scholar
  44. Powers JM, Schlaepfer WW, Willingham MC, Hall BJ (1981) An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations. J Neuropathol Exp Neurol 40: 592–612PubMedCrossRefGoogle Scholar
  45. Roseman JM, Buckley CE (1975) Inverse relationship between serum IgG concentration and measures of intelligence in elderly persons. Nature 254: 55–56PubMedCrossRefGoogle Scholar
  46. Rozemuller JM, Eikelenboom P, Stam FC (1986) Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch [B] 51: 247–254Google Scholar
  47. Rozemuller JM, Masters CL, Beyreuther K, Eikelenboom P, Stam FC (1987) Cerebral amyloidosis in Alzheimer’s disease. Senile plaques and congophilic angiopathy (abstract). In: Pepeu G et al. (eds) New trends in aging research. Sirmione, Italy, p 96Google Scholar
  48. Rozemuller JM, Eikelenboom P, Stam FC Blood-brain barrier dysfunction and Alzheimer’s disease. (Submitted for publication)Google Scholar
  49. Shirahama T, Skinner M, Westermark P, Rubinow A, Cohen AS, Brun A, Kemper TL (1982) Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion. Am J Pathol 107: 41–50Google Scholar
  50. Stam FC (1965) Histochemistry of the senile involution of the brain. In: Luthy F, Bischoff A (eds) Proceedings of the fifth international congress of neuropathology. Excerpta Medica, Amsterdam, pp 513–517Google Scholar
  51. Stam FC, Eikelenboom P (1985) Immunological study of cerebral senile amyloid (congophilic angiopathy and senile plaques). Interdise Top Gerontol 19: 127–130Google Scholar
  52. Stam FC, Rozemuller JM, Eikelenboom P. Immunopathological aspects of senile brain amyloidosis. In: Pepeu G et al. (eds) New trends in aging research. Sirmione, Italy, in pressGoogle Scholar
  53. Tavolato B, Argentiero V, (1980) Immunological indices in presenile Alzheimer’s disease. J Neurol Sci 46: 325–331PubMedCrossRefGoogle Scholar
  54. Torack RM, Lynch RG (1981) Cytochemistry of brain amyloid in adult dementia. Acta Neuropathol (Berl) 53: 189–196CrossRefGoogle Scholar
  55. Williams A, Papadopoulos N, Chase TN (1980) Demonstration of CSF gamma-globulin banding in presenile dementia. Neurology 30: 882–884PubMedGoogle Scholar
  56. Wisniewski HM, Kozlowski PB (1982) Evidence of blood brain barrier changes in senile dementia of the Alzheimer type. Ann NY Acad Sci 396: 119–129PubMedCrossRefGoogle Scholar
  57. Wisniewski HM, Merz GS (1983) Neuritic and amyloid plaques in senile dementia of the Alzheimer type. In: Katzman R (ed) Biological aspects of Alzheimer’s disease, Banbury report 15, Cold Spring Harbor, New York, pp 145–152Google Scholar
  58. Wisiniewski HM, Terry RD (1973) Reexamination of the pathogenesis of the senile plaque. In: Zimmermann HM (ed) Progress in neuropathology, vol II. Grune and Stratton, New York, pp 1–6Google Scholar
  59. Wisniewski HM, Moretz RC, Lossinsky AS (1981) Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent. Ann Neurol 10: 517–522PubMedCrossRefGoogle Scholar
  60. Wisniewski HM, Lossinsky AS, Moretz RC, Vorbrodt AW, Lassmann H, Carp RI (1983) Increased blood-brain barrier permeability in scrapie-infected mice. J Neuropathol Exp Neurol 42: 615–626PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • P. Eikelenboom
  • H. Fraser
  • J. M. Rozemuller
  • F. C. Stam

There are no affiliations available

Personalised recommendations